Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS)

TY - JOUR

T1 - Analysis of efficacy and safety in patients aged 65-75 years at randomization

T2 - Collaborative Atorvastatin Diabetes Study (CARDS)

AU - Neil, H Andrew W

AU - DeMicco, David A

AU - Luo, Don

AU - Betteridge, D John

AU - Colhoun, Helen M

AU - Durrington, Paul N

AU - Livingstone, Shona J

AU - Fuller, John H

AU - Hitman, Graham A

AU - CARDS Study Investigators

PY - 2006

Y1 - 2006

N2 - Rates of cardiovascular disease are highest in the elderly. Lipid-lowering statin therapy reduces the proportional risk as effectively in older patients as in younger individuals; however, limited data are available for elderly patients with type 2 diabetes. We conducted a post hoc analysis to compare the efficacy and safety of atorvastatin among 1,129 patients aged 65-75 years at randomization with 1,709 younger patients in the Collaborative Atorvastatin Diabetes Study (CARDS).

AB - Rates of cardiovascular disease are highest in the elderly. Lipid-lowering statin therapy reduces the proportional risk as effectively in older patients as in younger individuals; however, limited data are available for elderly patients with type 2 diabetes. We conducted a post hoc analysis to compare the efficacy and safety of atorvastatin among 1,129 patients aged 65-75 years at randomization with 1,709 younger patients in the Collaborative Atorvastatin Diabetes Study (CARDS).

U2 - 10.2337/dc06-0872

DO - 10.2337/dc06-0872

M3 - Article

C2 - 17065671

SN - 0149-5992

VL - 29

SP - 2378

EP - 2384

JO - Diabetes Care

JF - Diabetes Care

IS - 11

ER -